France· FR:62424059
NEGABAN 1 g, poudre pour solution injectable/pour perfusion
A medicinal product containing témocilline disodique, registered in France by EUMEDICA PHARMACEUTICALS (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TÉMOCILLINE DISODIQUE
- Manufacturer
- EUMEDICA PHARMACEUTICALS (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009300045241 flacon(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Témocilline disodique in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsNegaban 1 g poeder voor oplossing voor injectie/infusieEumedica Pharmaceuticals GmbH
- BelgiumNegaban 1 gEumedica Pharmaceuticals
- GermanyTemopenEumedica Pharmaceuticals Gmbh
- SpainCILOTEM 1 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSIONEumedica Pharmaceuticals Gmbh
- IrelandNegaban 1 g powder for solution for injection/infusionEumedica Pharmaceuticals GmbH
- SwedenNegaban 1 g Pulver till injektions-/infusionsvätska, lösningEumedica Pharmaceuticals GmbH
- United KingdomNegaban 1g powder for solution for injection vialsEumedica Pharma Ltd
- NorwayNegabanEumedica
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Belgium · Negaban
- Germany · Temopen
- Spain · Cilotem
- United Kingdom (Northern Ireland) · Negaban
- Ireland · Negaban
- Luxembourg · Negaban
- Netherlands · Negaban
- Sweden · Negaban
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0ae666a4-2663-40b2-bb88-2ef7d6d73265 GET /v1/drugs/0ae666a4-2663-40b2-bb88-2ef7d6d73265?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62424059",
"date_amm": "2014-12-23",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "TÉMOCILLINE DISODIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution injectable ou pour perfusion",
"voies_administration": "intramusculaire;intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about témocilline disodique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.